Analysts: Medtronic, Abbott stents to take major market share

09/6/2007 | Bloomberg

Analysts expect Abbott Laboratories' Xience and Medtronic's Endeavor drug-coated stents to grab one-third of the $5 billion stent market. "We have a new generation of stents that are easier to use and may have significant advantages in effectiveness and safety," one analyst said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN